| Name | Cellular Goods |
|---|---|
| Epic | CBX |
| Isin | GB00BK964W87 |
| Industry | Pharmaceuticals & Biotechnology |
| Latest share price | 0.38p | Net gearing | n/a |
|---|---|---|---|
| Market capitalisation | £2.26 | Debt ratio | n/a |
| Shares in issue | 602.25 | Debt-to-equity ratio | n/a |
| P/E ratio | n/a | Assets / equity ratio | n/a |
| Total dividends per share | n/a | Price to book value | n/a |
| Dividend yield | n/a | ROCE | -123.47 |
| Dividend cover | n/a | EPS growth | n/a |
| Earning per share | -1.18 | 52-week high / low | 0.28p / 1.33p |
| Type | Ex-date | Pay-date | Net-dividend |
|---|---|---|---|
| No dividends declared | |||
| Company name | Cellular Goods |
|---|---|
| Address | 16, Great Queen Street, London, United Kingdom, WC2B 5DG |
| Telephone | +44 (0)20 7031 6871 |
| Website | http://www.cellulargoods.co |
| Director | Position |
|---|---|
| Ms Anna Chokina | CEO |
| Mr Bruna Nikolla | CFO |
| Mr Gill Whitty-Collins | Non-Executive Director |
| Mr Misha Sher | Non-Executive Director |
| Mr Darcy Taylor | Non-Executive Chairman |
| Assets £ (m) | 2022 | 2021 | 2020 |
|---|---|---|---|
| Reporting date | 31/08/22 | 31/08/21 | 31/08/20 |
| Intangible asssets and goodwill | n/a | n/a | n/a |
| Investments and other non-current assets | n/a | n/a | n/a |
| Total non-current assets | n/a | n/a | n/a |
| Inventory / work in progress | 0.5 | 0.06 | n/a |
| Trade and other receivables | 0.25 | 0.36 | 0.09 |
| Cash and equivalents | 4.38 | 10.33 | 0.01 |
| Other current assets and asset held for resale | n/a | n/a | n/a |
| Total of all assets | 5.13 | 10.75 | 0.1 |
| Liabilities £ (m) | 2022 | 2021 | 2020 |
|---|---|---|---|
| Short term liabilities | 0.28 | 0.2 | 0.18 |
| Long term liabilities | n/a | n/a | n/a |
| Other liabilites / pension etc | n/a | n/a | n/a |
| Total of all liabilities | 0.28 | 0.2 | 0.18 |
| Net assets £ (m) | 2022 | 2021 | 2020 |
|---|---|---|---|
| Net assets | 4.85 | 10.55 | -0.08 |
| Equity £ (m) | 2022 | 2021 | 2020 |
|---|---|---|---|
| Share capital | 0.51 | 0.5 | 0.13 |
| Minority interests | n/a | n/a | n/a |
| Retained earnings | -9.73 | -3.74 | -0.41 |
| Share premium account | 12.51 | 12.49 | 0.2 |
| Total equity | 4.85 | 10.55 | -0.08 |
| Income £ (m) | 2022 | 2021 | 2020 |
|---|---|---|---|
| Turnover | n/a | n/a | n/a |
| Operating profit | -5.99 | -3.33 | -0.33 |
| Pre-tax profit | -5.99 | -3.33 | -0.33 |